Inspire Medical Systems (INSP) Capital Expenditures (2017 - 2026)

Inspire Medical Systems has disclosed Capital Expenditures across 10 years of filings, most recently posting $9.7 million for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $9.7 million, up 197.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.2 million (up 835.58% YoY), and the FY2025 annual result was $4.8 million, up 40.96% from the prior year.
• Capital Expenditures came in at $9.7 million for Q1 2026 at Inspire Medical Systems, up from -$476000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $9.7 million in Q1 2026 to a low of -$4.1 million in Q4 2022.
• The 5-year median for Capital Expenditures is $2.5 million (2025), against an average of $2.6 million.
• Across the five-year window, Capital Expenditures surged 161933.33% in 2023 and slumped 580.0% in 2025, its largest moves.
• Inspire Medical Systems' Capital Expenditures stood at -$4.1 million in 2022, then jumped by 296.94% to $8.0 million in 2023, then tumbled by 100.87% to -$70000.0 in 2024, then plunged by 580.0% to -$476000.0 in 2025, then soared by 2143.28% to $9.7 million in 2026.
• The last three Capital Expenditures figures came in at $9.7 million (Q1 2026), -$476000.0 (Q4 2025), and -$540000.0 (Q3 2025), per Business Quant data.